Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “AstraZeneca”

Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic PatientsTerminated
NCT05392959Phase 4Updated Apr 26, 2024
Sponsor: Centre Hospitalier Universitaire Saint Pierre
Diabetes Mellitus, Type 2
Belgium
Benralizumab Exacerbation StudyCompleted
NCT04102800Phase 4Updated Apr 25, 2024
Sponsor: NHS Greater Glasgow and Clyde
Asthma
United Kingdom
Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid TumorsCompleted
NCT02301130Phase 1Updated Apr 25, 2024
Sponsor: Kyowa Kirin, Inc.
Advanced Solid Tumors
United States
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)Completed
NCT03186209Phase 3Updated Apr 24, 2024
Sponsor: AstraZeneca
Asthma
China, Philippines, South Korea, Taiwan
Change in Symptom and Quality of Life in COPD by Budesonide/Glycopyrronium/Formoterol Fumarate Pressurized Metered Dose Inhaler (BGF pMDI)Completed
NCT05219630N/AUpdated Apr 23, 2024
Sponsor: AstraZeneca
Pulmonary Disease, Chronic Obstructive
Japan
A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)Completed
NCT04655027Phase 4Updated Apr 22, 2024
Sponsor: AstraZeneca
Anemia of Chronic Kidney Disease
China
Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.Completed
NCT06374043Phase 4Updated Apr 22, 2024
Sponsor: University Medical Center Groningen
Diabetes Mellitus, Type 2 · Diabetes Mellitus Type 2 With Proteinuria · Diabetes Mellitus · Diabetes
Netherlands
Quetiapine for Cocaine Use and CravingsCompleted
NCT00232336Phase 4Updated Apr 19, 2024
Sponsor: Seattle Institute for Biomedical and Clinical Research
Cocaine-Related Disorders · Substance-Related Disorders
United States
Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric CancerUnknown
NCT03579784Phase 2Updated Apr 19, 2024
Sponsor: Do-Youn Oh
Advanced Gastric Cancer
South Korea
Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic CancerUnknown
NCT03572400Phase 2Updated Apr 19, 2024
Sponsor: Do-Youn Oh
Pancreatic Cancer
South Korea
TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertensionTerminated
NCT05268926Phase 2Updated Apr 17, 2024
Sponsor: University Medical Center Groningen
Albuminuria
Netherlands
PACED-digitized Support During Adjuvant Endocrine TherapyUnknown
NCT05084625NAUpdated Apr 17, 2024
Sponsor: Region Stockholm
Breast Cancer · Treatment Adherence · Quality of Life · Treatment Side Effects
Sweden
OPTIMISE-CKD Drug UtilizationCompleted
NCT05932901N/AUpdated Apr 17, 2024
Sponsor: AstraZeneca
Chronic Kidney Disease
United States, Japan, Sweden
GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 DiabetesTerminated
NCT03029351Phase 4Updated Apr 16, 2024
Sponsor: University at Buffalo
Type2 Diabetes · Kidney Diseases
United States
An Open-label, Phase II Study of AZD4635 in Patients With Prostate CancerCompleted
NCT04089553Phase 2Updated Apr 16, 2024
Sponsor: AstraZeneca
Prostate Cancer · Metastatic Castration-Resistant Prostate Cancer (mCRPC)
United States
LatInamerican Vaccine Effectiveness Against Hospitalizations Due to Circulating COVID-19 VoC RWE StudyCompleted
NCT05282017N/AUpdated Apr 15, 2024
Sponsor: AstraZeneca
COVID-19, SARS-CoV-2
Brazil, Colombia, Costa Rica, Mexico, Panama
A Trial of Radiotherapy and Durvalumab in DLBCL and FLCompleted
NCT03610061Phase 1Updated Apr 12, 2024
Sponsor: Austin Health
Diffuse Large B Cell Lymphoma · Follicular Lymphoma
Australia
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid TumorsCompleted
NCT03490669Phase 1Updated Apr 5, 2024
Sponsor: AstraZeneca
Advanced Solid Tumors · Pancreatic Cancer · Non Small Cell Lung Cancer · Ovarian Cancer
United States, Canada, Spain
Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy SubjectsCompleted
NCT04788641Phase 1Updated Apr 5, 2024
Sponsor: AstraZeneca
Hyperkalaemia
Germany
Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLLWithdrawn
NCT05465876Phase 2Updated Apr 4, 2024
Sponsor: Sunnybrook Health Sciences Centre
Chronic Lymphocytic Leukemia · COVID-19
Canada
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)Completed
NCT01942135Phase 3Updated Apr 4, 2024
Sponsor: Pfizer
Metastatic Breast Cancer
United States, Australia, Belgium, Canada, Germany +12 more
Intermittent Dosing Of Selumetinib In Childhood NF1 Associated TumoursCompleted
NCT03326388Phase 1, Phase 2Updated Apr 4, 2024
Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust
Neurofibromatosis Type 1 · Plexiform Neurofibroma · Optic Nerve Glioma
United Kingdom
GR Defect in Sputum Cells in COPDWithdrawn
NCT00159276N/AUpdated Apr 4, 2024
Sponsor: Imperial College London
Chronic Obstructive Pulmonary Disease (COPD)
United Kingdom
An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.Completed
NCT03433924N/AUpdated Mar 27, 2024
Sponsor: AstraZeneca
Urinary Bladder Cancer
China
Improving Knowledge in Heart Failure Inpatient With Therapeutic EducationTerminated
NCT05751772NAUpdated Mar 26, 2024
Sponsor: University Hospital, Geneva
Heart Failure With Reduced Ejection Fraction · Heart Failure; With Decompensation · Pharmacist-Patient Relations · Medication Adherence
Switzerland

Previous page Next page